CEO Martin Lehr Named Ernst & Young 2018 Entrepreneur of the Year Semifinalist
Context Therapeutics Announces the Acquisition of Apristor™ (Onapristone XR)
PHILADELPHIA, Pa.--(BUSINESS WIRE)—Context Therapeutics, a clinical-stage biopharmaceutical company focused on hormonally-driven cancers, announced that CEO Martin Lehr is a semifinalist for Ernst, & Young’s (EY) 2018 Entrepreneur of the Year for the Philadelphia region.
Context Therapeutics Announces Senior Leadership Appointments
PHILADELPHIA, PA--Context Therapeutics, a clinical stage biopharmaceutical company announced that it has acquired worldwide rights to Apristor.
PHILADELPHIA--(BUSINESS WIRE)--Context Therapeutics announced the appointments of Scott Applebaum as its President and Richard Morris as its EVP and CFO.